C. Hartmann

T. Steiner, C. Hartmann, E. Hund, 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

MYCN amplification drives an aggressive form of spinal ependymoma

David T. W. Jones, M. Kool, S. Yip, 2019, Acta Neuropathologica.

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

David T. W. Jones, G. Reifenberger, M. Weller, 2018, Acta Neuropathologica.

Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity

F. Heppner, A. Unterberg, A. von Deimling, 2020, Acta Neuropathologica.

Analysis of CIC‐associated CpG island methylation in oligoastrocytoma

A. von Deimling, C. Hartmann, F. Sahm, 2013, Neuropathology and applied neurobiology.

Surgical Approaches to Medullary Tumors

C. Hartmann, H. Bertalanffy, Souvik Kar, 2020 .

Primary intracranial leiomyosarcoma of the torcular Herophili associated with Fanconi anemia and allogenic stem cell transplantation

J. Krauss, C. Hartmann, E. Hermann, 2014, Child's Nervous System.

IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody

R. Penzel, H. Zentgraf, A. von Deimling, 2010, Haematologica.

Combined treatment of pediatric high‐grade glioma with the oncolytic viral strain MTH‐68/H and oral valproic acid

C. Hartmann, F. Zintl, L. Csatary, 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Microglia damage precedes major myelin breakdown in X‐linked adrenoleukodystrophy and metachromatic leukodystrophy

W. Brück, C. Hartmann, C. Stadelmann, 2019, Glia.

Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress

C. Hartmann, I. Dokic, A. Régnier-Vigouroux, 2012, Glia.

Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC

S. Bens, R. Siebert, M. Kool, 2022, Neuropathology and applied neurobiology.

Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients

M. Hartmann, A. Unterberg, C. Wirtz, 2009, Acta Neurochirurgica.

Diagnostic red flags: steroid‐treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination

G. Reifenberger, W. Brück, C. Hartmann, 2018, Brain pathology.

Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.

A. von Deimling, J. Tonn, H. Kretzschmar, 2011, Neuro-oncology.

Molecular Genetic Analysis of Oligodendroglial Tumors

A. von Deimling, C. Hartmann, S. Kamel‐Reid, 2005, Journal of neuropathology and experimental neurology.

Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857

J. Debus, K. Herfarth, W. Wick, 2008 .

Delayed Distant Spinal Metastasis in Thymomas

A. Ganser, J. Krauss, C. Hartmann, 2013, Spine.

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

Martin Sill, Alexander Radbruch, Volker Hovestadt, 2014, Acta Neuropathologica.

Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.

A. von Deimling, J. Debus, C. Hartmann, 2012, International journal of radiation oncology, biology, physics.

Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma: A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033).

M. Hassel, K. Hoang-Xuan, R. Stupp, 2013 .

Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase

A. von Deimling, W. Wick, C. Hartmann, 2012, PloS one.

Novel PLA2G4C Polymorphism as a Molecular Diagnostic Assay for 19q Loss in Human Gliomas

D. Louis, C. Hartmann, R. Jenkins, 2002, Brain pathology.

PIK3CA mutations in oligodendroglial tumours

A. von Deimling, C. Hartmann, N. Holtkamp, 2006, Neuropathology and applied neurobiology.

Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types

Se Hoon Kim, G. Reifenberger, A. Becker, 2022, Neuropathology and applied neurobiology.

Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05)

M. Weller, U. Bogdahn, W. Wick, 2011, Journal of Neuro-Oncology.

Radiochemotherapy with daily concomitant and adjuvant one week on/one week off temozolomide plus indomethacin in newly diagnosed glioblastoma: A phase II trial

M. Weller, W. Wick, C. Hartmann, 2008 .

A clinicopathological and genetic study of sporadic diffuse leukoencephalopathy with spheroids: a report of two cases

A. von Deimling, C. Hartmann, N. Araki, 2013, Neuropathology and applied neurobiology.

Monoclonal antibody specific for IDH1 R132H mutation

H. Zentgraf, D. Capper, C. Hartmann, 2009, Acta Neuropathologica.

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

Kirsten Schmieder, Pieter Wesseling, Andrey Korshunov, 2011, Acta Neuropathologica.

Pediatric intracranial primary anaplastic ganglioglioma

C. Hartmann, H. Bertalanffy, C. Di Rocco, 2017, Child's Nervous System.

Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas—differences in mutation profiles in epithelial-derived oropharyngeal neoplasms

C. Hartmann, U. Lehmann, H. Kreipe, 2018, Virchows Archiv.

Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.

H. Zentgraf, A. von Deimling, T. Luft, 2010, Leukemia research.

Genome-Wide Sequencing Reveals Small Nucleolar RNAs Downregulated in Cerebral Cavernous Malformations

R. Geffers, A. Samii, C. Hartmann, 2018, Cellular and Molecular Neurobiology.

Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones

P. Wen, D. Louis, P. Black, 2000, Journal of neuropathology and experimental neurology.

Abstract 3687: An integrative genomics approach identifies distinct molecular and epigenetic subgroups of pediatric glioblastoma

David T. W. Jones, G. Reifenberger, C. Plass, 2012 .

Rapidly progressive paraplegia due to an extradural lumbar meningocele mimicking a cyst. Case report.

M. Brock, C. Hartmann, R. Stendel, 2007, Journal of neurosurgery. Spine.

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

David T. W. Jones, M. Kool, M. Weller, 2013, Acta Neuropathologica.

Stereotactic biopsy of a brain lesion caused by hormographiella aspergillata

A. Ganser, J. Krauss, P. Raab, 2022, Surgical neurology international.

Melanotic Tumors of the Nervous System are Characterized by Distinct Mutational, Chromosomal and Epigenomic Profiles

Volker Hovestadt, Felix Sahm, David T. W. Jones, 2015, Brain pathology.

DNA methylation-based classification of central nervous system tumours

Till Acker, Pieter Wesseling, Martin Sill, 2018, Nature.

Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival

Michael Sabel, Andrey Korshunov, Bernhard Radlwimmer, 2009, Clinical Cancer Research.

The sellar and suprasellar region: A “hideaway” of rare lesions. Clinical aspects, imaging findings, surgical outcome and comparative analysis

J. Krauss, P. Raab, C. Hartmann, 2016, Clinical Neurology and Neurosurgery.

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases

L. Schnitzler, A. Ferbert, P. van Damme, 2017, Orphanet Journal of Rare Diseases.

Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling for transcriptomic analysis

M. Sorokin, A. Garazha, A. Buzdin, 2021, Cold Spring Harbor molecular case studies.

Inclusion bias of patients with genetically different glioblastoma subgroups in clinical trials.

C. Hartmann, 2018, Neuro-oncology.

Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations

G. Reifenberger, M. Weller, M. Loeffler, 2013, Clinical Cancer Research.

Molecular signatures classify astrocytic gliomas by IDH1 mutation status

M. Wolter, G. Reifenberger, P. Lichter, 2011, International journal of cancer.

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.

G. Reifenberger, M. Weller, G. Nikkhah, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms

I. Petersen, D. Capper, C. Hartmann, 2014, Acta Neuropathologica.

NDRG1 prognosticates the natural course of disease in WHO grade II glioma

M. Weller, M. Westphal, W. Wick, 2014, Journal of Neuro-Oncology.

Interlaboratory comparison of IDH mutation detection

K. Aldape, M. Sanson, M. Bent, 2013, Journal of Neuro-Oncology.

PIK3CA mutations in glioblastoma multiforme

Christian Hartmann, Andreas von Deimling, C. Hartmann, 2005, Acta Neuropathologica.

Sarcoma classification by DNA methylation profiling

David T. W. Jones, S. Fröhling, I. Petersen, 2021, Nature Communications.

Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling

Gabriele Schackert, Andreas von Deimling, Markus Loeffler, 2014, International journal of cancer.

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO

Pieter Wesseling, Jaap C. Reijneveld, Volker Hovestadt, 2015, Acta Neuropathologica.

DNA hypermethylation and Aberrant Expression of the EMP3 Gene at 19q13.3 in Human Gliomas

Jörg van den Boom, M. Wolter, G. Reifenberger, 2007, Brain pathology.

Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs.

Amir Samii, Christian Hartmann, Nicolas Borisov, 2018, Seminars in cancer biology.

Chromosome 22 tiling‐path array–CGH analysis identifies germ‐line‐ and tumor‐specific aberrations in patients with glioblastoma multiforme

A. von Deimling, A. Piotrowski, T. de Ståhl, 2005, Genes, chromosomes & cancer.

Methylation-based classification of benign and malignant peripheral nerve sheath tumors

Volker Hovestadt, Stefan M. Pfister, Arie Perry, 2016, Acta Neuropathologica.

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

G. Reifenberger, C. Plass, M. Weller, 2016, Oncotarget.

Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.

A. von Deimling, C. Hartmann, R. Friedrich, 2006, Carcinogenesis.

Subclassification of Nerve Sheath Tumors by Gene Expression Profiling

C. Hartmann, A. Deimling, R. Friedrich, 2004, Brain pathology.

Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14

M. Kool, S. Pfister, E. Aronica, 2019, Neuropathology and applied neurobiology.

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Gabriele Schackert, Markus Loeffler, Hans Binder, 2015, Acta Neuropathologica.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma

Brigitta G. Baumert, Jaap C. Reijneveld, Andreas von Deimling, 2016, The Lancet. Oncology.

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.

G. Reifenberger, M. Weller, C. Meisner, 2015, Neuro-oncology.

Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma

David T. W. Jones, S. Pfister, W. Wick, 2014, Acta Neuropathologica.

Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors

H. Zentgraf, A. von Deimling, A. Korshunov, 2010, Brain pathology.

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

G. Reifenberger, M. Weller, A. von Deimling, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q

G. Reifenberger, P. Lichter, C. Hartmann, 2007, Oncogene.

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma

A. Brandes, C. Hartmann, M. Ermani, 2016, Oncotarget.

Diagnostic markers for glioblastoma.

A. Unterberg, C. Hartmann, C. S. Jung, 2011, Histology and histopathology.

Immunohistochemical analysis of 1844 human epithelial and haematopoietic tumours and sarcomas for IDH1R132H mutation

I. Petersen, A. von Deimling, D. Capper, 2011, Histopathology.

Review Diagnostic markers for glioblastoma

C. Hartmann, C. S. Jung, 2011 .

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients’ individual gene expression in peripheral blood

M. Hecker, C. Hartmann, H. Thiesen, 2013, Molecular Neurobiology.

Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance

Dirk Koczan, Michael Hecker, M. Hecker, 2012, Journal of Neuroinflammation.

Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours

F. Heppner, A. von Deimling, C. Hartmann, 2012, PloS one.

Oligosarcomas, IDH-mutant are distinct and aggressive

T. Acker, D. Schrimpf, A. von Deimling, 2021, Acta Neuropathologica.

Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis

David T. W. Jones, Sybren L. N. Maas, M. Kloor, 2020, Acta Neuropathologica.

Infratentorial IDH-mutant astrocytoma is a distinct subtype

David T. W. Jones, S. Pfister, T. Acker, 2020, Acta Neuropathologica.

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.

Martin Sill, Michael Platten, Volker Hovestadt, 2014, Neuro-oncology.

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

R. Mirimanoff, R. Stupp, W. Mason, 2012, Acta Neuropathologica.

LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild‐type glioblastoma patients

Andreas von Deimling, Andreas Mock, Rolf Warta, 2016, International journal of cancer.

Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

David T. W. Jones, Sybren L. N. Maas, K. Aldape, 2021, Acta Neuropathologica.

Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA

David T. W. Jones, G. Reifenberger, S. Pfister, 2019, Acta Neuropathologica.

FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma

David T. W. Jones, G. Reifenberger, S. Pfister, 2018, Acta Neuropathologica.

BRAF‐Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 Expression

A. Becker, M. Preusser, D. Capper, 2014, Brain pathology.

No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas

A. Unterberg, W. Wick, D. Capper, 2012, Journal of Neuro-Oncology.

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?

Andreas von Deimling, Jürgen Debus, Stephanie E Combs, 2011, Radiation oncology.

Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology

D. Capper, C. Hartmann, A. Deimling, 2011, Acta Neuropathologica.

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes

M. Essig, K. Schmieder, C. Hartmann, 2010, Acta Neuropathologica.

PCR‐ and Restriction Endonuclease‐Based Detection of IDH1 Mutations

A. von Deimling, D. Capper, C. Hartmann, 2010, Brain pathology.

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma

Hendrik Witt, Andrey Korshunov, Christian Hartmann, 2009, Acta Neuropathologica.

Novel oncogene amplifications in tumors from a family with Li–Fraumeni syndrome

B. Burkhardt, P. Lichter, S. Pfister, 2009, Genes, chromosomes & cancer.

Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma

A. von Deimling, Guojun Wu, C. Hartmann, 2013, Cell cycle.

No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma

A. von Deimling, C. Hartmann, G. Henze, 2004, International journal of cancer.

Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.

A. von Deimling, C. Hartmann, M. Plotkin, 2007, Journal of neurosurgery.

Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis

Martin A. M. Reijns, G. Reifenberger, M. Weller, 2017, Acta Neuropathologica.

Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors

K. Hoffmann, C. Hartmann, A. Deimling, 2004, Acta Neuropathologica.

Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

S. Pfister, U. Schüller, C. Hartmann, 2023, bioRxiv.

Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures

A. Samii, C. Hartmann, U. Lehmann, 2021, PloS one.

Histology and Molecular Pathology of Pediatric Brain Tumors

S. Pfister, A. Korshunov, C. Hartmann, 2009, Journal of child neurology.

Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma

M. Weller, A. von Deimling, W. Wick, 2012, PloS one.

Pathology and molecular genetics of oligodendroglial tumors

C. Hartmann, A. Deimling, W. Mueller, 2004, Journal of Molecular Medicine.

Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring

G. Fuellen, C. Hartmann, A. Hermann, 2021, Frontiers in Genetics.

The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis

G. Reifenberger, M. Boutros, A. von Deimling, 2012, EMBO molecular medicine.

Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

David T. W. Jones, C. Sommer, J. Mora, 2018, Acta Neuropathologica.

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations

Roland Eils, Rainer König, Rosario M. Piro, 2013, Acta Neuropathologica.

Molecular genetics of meningiomas: from basic research to potential clinical applications.

C. Hartmann, M. Simon, J. Boström, 2007, Neurosurgery.

NF2 Mutations in Secretory and Other Rare Variants of Meningiomas

C. Hartmann, A. Deimling, W. Paulus, 2006, Brain pathology.

Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence

C. Hartmann, S. Kropf, C. Mawrin, 2017, Neuro-oncology.

Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.

A. von Deimling, J. Debus, C. Hartmann, 2011, International journal of radiation oncology, biology, physics.

The new WHO 2016 classification of brain tumors—what neurosurgeons need to know

C. Hartmann, Rouzbeh Banan, 2017, Acta Neurochirurgica.

Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms

D. Louis, A. Stemmer-Rachamimov, C. Hartmann, 2003, International journal of cancer.

An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice.

David T. W. Jones, S. Heiland, P. Lichter, 2011, The Journal of clinical investigation.

AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry

David T. W. Jones, S. Pfister, A. Becker, 2013, Acta Neuropathologica.

Connexin expression by radial glia-like cells is required for neurogenesis in the adult dentate gyrus

Andreas Hofmann, Christian Steinhäuser, Christian Hartmann, 2009, Proceedings of the National Academy of Sciences.

Surgical Treatment of Spinal Ependymomas: Experience in 49 Patients.

J. Krauss, C. Hartmann, H. Heissler, 2018, World neurosurgery.

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas

V. Rohde, C. Hartmann, C. Stadelmann, 2019, Acta Neuropathologica Communications.

KINFix – A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimens

J. Hainfellner, M. Preusser, C. Hartmann, 2015, Clinical neuropathology.

Genome-Wide Sequencing Reveals Small Nucleolar RNAs Downregulated in Cerebral Cavernous Malformations

R. Geffers, A. Samii, C. Hartmann, 2018, Cellular and Molecular Neurobiology.

Hypertrophic pachymeningoencephalitis associated with temporal giant cell arteritis

C. Hartmann, Sven Duda, H. Wessling, 2018, BMJ Case Reports.

J. Krauss, C. Hartmann, M. Esmaeilzadeh, 2022, Acta Neurochirurgica.

Intracranial foreign material granulomas after cranial surgery

J. Krauss, Gökce Hatipoglu Majernik, C. Hartmann, 2018, Acta neurochirurgica.

Desmoplastic infantile astrocytoma with multiple intracranial and intraspinal localizations at presentation

J. Krauss, C. Hartmann, E. Hermann, 2015, Child's Nervous System.

Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?

G. Reifenberger, M. Weller, J. Schramm, 2011, Clinical Cancer Research.

Human Borna disease virus 1 (BoDV-1) encephalitis cases in the north and east of Germany

T. Mayer, C. Hartmann, D. Brämer, 2021, Emerging microbes & infections.

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.

Andreas von Deimling, Michael Weller, David N Louis, 2002, The American journal of pathology.

Increased Mitotic and Proliferative Activity Are Associated With Worse Prognosis in Papillary Tumors of the Pineal Region

I. Blümcke, T. Acker, I. Vajtai, 2014, The American journal of surgical pathology.

A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma

J. Pichler, I. Harting, A. von Deimling, 2014, Clinical Cancer Research.

Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin

J. Krauss, A. Samii, C. Hartmann, 2021, Acta Neuropathologica.

Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling

G. Reifenberger, P. Lichter, A. von Deimling, 2006, International journal of cancer.

Oligodendrogliomas: impact of molecular genetics on treatment.

A. von Deimling, C. Hartmann, A. Deimling, 2005, Neurology India.

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

C. Hartmann, U. Lehmann, Arne Christians, 2017, Acta neuropathologica communications.

Combined 1p/19q Loss in Oligodendroglial Tumors: Predictive or Prognostic Biomarker?

M. Weller, J. Schramm, M. Loeffler, 2007, Clinical Cancer Research.

Molecular pathology of oligodendroglial tumors.

A. von Deimling, C. Hartmann, 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.

A. von Deimling, W. Wick, C. Hartmann, 2013, Neuro-oncology.

Cerebellar glioblastoma: a clinical series with contemporary molecular analysis

J. Krauss, M. Lalk, C. Hartmann, 2018, Acta Neurochirurgica.

IDH1 Mutation in Brain Stem Glioma: Case Report and Review of Literature

A. Samii, C. Hartmann, G. F. Walter, 2018, Asian journal of neurosurgery.

Gliomatosis Cerebri: Implications of Genetic Findings

C. Hartmann, M. Seiz, 2014 .

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

C. Hartmann, A. Deimling, F. Sahm, 2012, Acta Neuropathologica.

IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom

Christian Hartmann, Andreas von Deimling, Martin Misch, 2012, Seizure.

Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes

A. von Deimling, D. Capper, C. Hartmann, 2010, The American journal of surgical pathology.

Erdheim-Chester disease mimicking an intracranial trigeminal schwannoma: case report.

M. Samii, C. Hartmann, Maysam Alimohamadi, 2015, Journal of neurosurgery. Pediatrics.

STENTING OF THE TUBA AUDITIVA EUSTACHII AS A VALID TREATMENT CONCEPT IN CHRONIC OTITIS MEDIA , CHRONIC AUDITORY TUBE DYSFUNCTION AND ITS SEQUELAE : IMPLEMENTATION OF A LARGE ANIMAL MODEL

H. Sudhoff, C. Hartmann, H. Nothwang, 2016 .

Fetal MRI demonstrates glioependymal cyst in a case of sonographic unilateral ventriculomegaly

C. Hartmann, R. Klingebiel, M. Mühler, 2007, Pediatric Radiology.

Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors.

G. Reifenberger, P. Lichter, R. Martínez, 2011, Journal of the National Cancer Institute.

The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas

J. Krauss, C. Hartmann, F. Sahm, 2021, Neuropathology and applied neurobiology.

Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel–Lindau disease‐related tumours

F. Heppner, A. von Deimling, D. Capper, 2021, Neuropathology and applied neurobiology.

Challenges in cerebrospinal fluid shunting in patients with glioblastoma

J. Krauss, C. Hartmann, H. Heissler, 2018, Fluids and Barriers of the CNS.

Analysis of Astroglial K+ Channel Expression in the Developing Hippocampus Reveals a Predominant Role of the Kir4.1 Subunit

Devin K. Binder, Christian Steinhäuser, Christian Hartmann, 2009, The Journal of Neuroscience.

Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

David T. W. Jones, G. Reifenberger, K. Aldape, 2020, Acta Neuropathologica.

Scientific Correspondence

A. von Deimling, C. Hartmann, F. Sahm, 2011, Nature.

FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS).

J. Hainfellner, M. Preusser, C. Hartmann, 2011, Clinical neuropathology.

Mutational analysis of D2HGDH and L2HGDH in brain tumours without IDH1 or IDH2 mutations

A. von Deimling, K. Schmieder, C. Hartmann, 2011, Neuropathology and applied neurobiology.

Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.

D. Louis, L. Ashworth, C. Hartmann, 2002, Cancer research.

Carbon ion radiation therapy for high-risk meningiomas.

A. von Deimling, J. Debus, C. Karger, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chromosomal imbalances and NF2 mutational analysis in a series of 10 spinal nerve sheath myxomas

A. von Deimling, C. Hartmann, W. Paulus, 2007, Histopathology.

PROX1 is a predictor of survival for gliomas WHO grade II

A. von Deimling, C. Hartmann, M. Lindström, 2011, British Journal of Cancer.

Chromogenic in situ Hybridization is a Reliable Alternative to Fluorescence in situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin‐Embedded Gliomas

A. von Deimling, D. Capper, C. Hartmann, 2013, Brain pathology.

Estimating cancer survival and clinical outcome based on genetic tumor progression scores

Thomas Lengauer, Niko Beerenwinkel, Christian Hartmann, 2005, Bioinform..

The Potential of Relaxation-Weighted Sodium Magnetic Resonance Imaging as Demonstrated on Brain Tumors

Wolfhard Semmler, Alexander Radbruch, Michael Bock, 2011, Investigative radiology.

Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia‐oculomotor apraxia 4 and pilocytic astrocytoma

D. Steinemann, T. Illig, M. Golas, 2018, Clinical genetics.

Severe Subarachnoid Hemorrhage Due to Fusiform Lateral Anterior (A1) Artery Perforator Aneurysm with "Spontaneous Resolution".

J. Krauss, Gökce Hatipoglu Majernik, P. Raab, 2018, World Neurosurgery.

Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas

J. Krauss, H. Lanfermann, A. Samii, 2022, Cancers.

Epigenetically mediated downregulation of the differentiation‐promoting chaperon protein CRABP2 in astrocytic gliomas

C. Plass, A. Unterberg, A. von Deimling, 2012, International journal of cancer.

Multiple desmoplastic infantile gliomas—therapeutic challenges

J. Krauss, C. Hartmann, E. Hermann, 2015, Child's Nervous System.

Evidence for a low‐penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6

R. Siebert, M. Heuser, U. Schüller, 2021, Pediatric blood & cancer.

Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma

M. Barboza, V. Rohde, W. Brück, 2020, PloS one.

Identification of distinctive features in human intracranial tumors by label‐free nonlinear multimodal microscopy

Edmund Koch, Matthias Kirsch, Gabriele Schackert, 2019, Journal of biophotonics.

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

David T. W. Jones, G. Reifenberger, M. Weller, 2019, Acta Neuropathologica Communications.

No preferential loss of paternal 19q alleles in oligodendroglial tumors

A. von Deimling, W. Wick, C. Hartmann, 2003, Annals of neurology.

Preliminary application of native Nephila edulis spider silk and fibrin implant causes granulomatous foreign body reaction in vivo in rat’s spinal cord

C. Peck, C. Hartmann, M. Wilhelmi, 2022, PloS one.

Determining the glioma CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide methylation data in the biomarker cohort of the NOA-04 trial.

G. Reifenberger, M. Weller, V. Hovestadt, 2014 .

Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.

C. Hartmann, I. Sandalcioglu, K. Stein, 2017, World neurosurgery.

Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma

C. Plass, A. Unterberg, A. von Deimling, 2015, Glia.

Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis

P. Raab, C. Hartmann, M. Stangel, 2015, Journal of Neuroinflammation.

Challenges in cerebrospinal fluid shunting in patients with glioblastoma

J. Krauss, C. Hartmann, H. Heissler, 2018, Fluids and Barriers of the CNS.

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas

V. Rohde, C. Hartmann, C. Stadelmann, 2019, Acta Neuropathologica Communications.

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma

A. von Deimling, C. Hartmann, D. Krunic, 2023, bioRxiv.

Sertraline for Functional Recovery After Acute Ischemic Stroke: A Prospective Observational Study

H. Reichmann, C. Hartmann, T. Siepmann, 2021, Frontiers in Neurology.

DNA methylation-based classification of central nervous system tumours

David T. W. Jones, Nils W. Engel, Anne K. Braczynski, 2018, Nature.

Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis

C. Hartmann, U. Pleyer, L. Bergmann, 2001, The British journal of ophthalmology.

Pediatric rosette-forming glioneuronal tumor of the septum pellucidum

J. Krauss, C. Hartmann, E. Hermann, 2020, Child's Nervous System.